Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-11 5:14 pm Purchase |
2020-12-31 | 13G | GlycoMimetics, Inc. GLYC |
BIOTECHNOLOGY VALUE FUND L P | 9,544,262 19.960% |
2,182,461 (+29.65%) |
Filing History |
| 2021-02-10 10:57 am Purchase |
2020-12-31 | 13G | GlycoMimetics, Inc. GLYC |
VANGUARD GROUP INC | 2,569,239 5.370% |
2,569,239 (New Position) |
Filing History |
| 2021-01-29 09:57 am Sale |
2020-12-31 | 13G | GlycoMimetics, Inc. GLYC |
BlackRock Inc. BLK |
2,616,477 5.500% |
-212,034 (-7.50%) |
Filing History |
| 2020-12-10 08:12 am Sale |
2020-11-30 | 13G | GlycoMimetics, Inc. GLYC |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
-4,831,896 (Position Closed) |
Filing History |
| 2020-07-20 4:34 pm Purchase |
2020-07-10 | 13G | GlycoMimetics, Inc. GLYC |
EcoR1 Capital LLC | 2,909,800 6.700% |
2,909,800 (New Position) |
Filing History |
| 2020-07-10 3:18 pm Sale |
2020-07-10 | 13G | GlycoMimetics, Inc. GLYC |
Invesco Ltd. IVZ |
39,273 0.100% |
-2,349,033 (-98.36%) |
Filing History |